Back

Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Pulmonary circulation, pulmonary embolism, right heart failure e-posters Pulmonary Hypertension ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Katherine Kearney

St Vincents Hospital, Sydney (Australia)

73 More presentations in this session

Presentation thumbnail
The novel noninvasive method for prediction of long-term specific therapy efficacy in patients with IPAH and inoperable CTEPH
Mrs I. Lyapina (Kemerovo, RU)
Abstract Slides
Presentation thumbnail
Early and long term prognostic accuracy of 4 acute pulmonary embolism mortality risk scores
Doctor L. Oliveira (Ponta Delgada, PT)
Abstract Slides
Presentation thumbnail
Novel genetic and molecular pathways in pulmonary arterial hypertension associated with connective tissue disease
Doctor I. Hernandez Gonzalez (Valladolid, ES)
Abstract Slides
Presentation thumbnail
Role of echocardiography to avoid misclassification of pulmonary hypertension associated with left heart disease as precapillary pulmonary hypertension.
Assistant Professor J. Grignola Rial (Montevideo, UY)
Abstract Slides
Presentation thumbnail
Survival of patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension listed for lung transplantation
Doctor I. Magnani (Bologna, IT)
Abstract

Access the full session

Session thumbnail
Pulmonary circulation, pulmonary embolism, right heart failure e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources